Hemabate side effects by duration, gender and age - a phase IV clinical study of FDA data
Side effects are reported by people who take Hemabate. Common side effects include vomiting among females and trisomy 18 among males.
The phase IV clinical study is created by eHealthMe based on 271 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
271 people who take Hemabate and have side effects are studied.
What is Hemabate?
Hemabate has active ingredients of carboprost tromethamine. eHealthMe is studying from 273 Hemabate users for its effectiveness, alternative drugs and more.
Number of Hemabate reports submitted per year:
Hemabate side effects by time on the drug *:
Hemabate side effects by gender *:
Hemabate side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Hemabate?Personalize this study to your gender and age
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on carboprost tromethamine (the active ingredients of Hemabate) and Hemabate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Alternative drugs to, pros and cons of Hemabate:
- Hemabate (273 reports)
All Hemabate side effects from A to Z:a b c d e f g h i j k l m n o p q r s t u v w x y z
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Niaspan and Klebsiella Infection - 9 seconds ago
- Accolate and Darvocet-N 100 drug interaction - 10 seconds ago
- Prograf and Oxycontin drug interaction - 11 seconds ago
- Invega and Therapeutic Response Increased - 20 seconds ago
- Humulin N and Head Discomfort - 25 seconds ago
- Potassium Chloride and Muscle Twitching - 28 seconds ago
- Ceftazidime and Corneal Thinning - 29 seconds ago
- Voltaren and Tongue Biting - 30 seconds ago
- Qutenza and Rash Erythematous Aggravated - 37 seconds ago
- Ankylosing Spondylitis and Hypersensitivity - 41 seconds ago